SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001688530-24-000001
Filing Date
2024-07-09
Accepted
2024-07-09 17:48:42
Documents
1
Period of Report
2024-07-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5395
  Complete submission text file 0001688530-24-000001.txt   7198
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1120 S CAPITAL OF TX HWY BLDG 1, STE 300 AUSTIN TX 78746
Business Address
Cavanaugh Stefanie L. (Reporting) CIK: 0001688530 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 241108249